[1] Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337. DOI:
10.1038/nrd.2016.268[2] DAPENG LI . AGCM-22, a novel cetuximab-based EGFR-targeting antibody-drug-conjugate with highly selective anti-glioblastoma efficacy[J]. Bioorganic & Medicinal Chemistry, 2024, 102: Article 117657. DOI:
10.1016/j.bmc.2024.117657[3] SHIYONG FAN . Novel antibody-antibiotic conjugate using KRM-1657 as payload eliminates intracellular MRSA in vitro and in vivo[J]. Bioorganic Chemistry, 2024, 150: Article 107532. DOI:
10.1016/j.bioorg.2024.107532
